Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial

OBJECTIVE: To assess efficacy and safety of fulranumab, a fully human monoclonal antibody against nerve growth factor, in patients with diabetic peripheral neuropathic pain (DPNP). METHODS: In this phase II, double-blind, placebo-controlled trial, patients with moderate to severe DPNP were randomize...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Hao, Romano, Gary, Frustaci, Mary Ellen, Bohidar, Norm, Ma, Huizhong, Sanga, Panna, Ness, Seth, Russell, Lucille J., Fedgchin, Margaret, Kelly, Kathleen M., Thipphawong, John
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141990/
https://ncbi.nlm.nih.gov/pubmed/25008392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000686
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados